Life sciences is ‘going through rapid change’ – opening a software opportunity

Evan Floden tells us about the risk of starting Seqera Labs, the opportunities in sequencing and the challenge of growing into a CEO role. Read more: Life sciences is ‘going through rapid change’ – opening a software opportunity

Life sciences is ‘going through rapid change’ – opening a software opportunity

Evan Floden tells us about the risk of starting Seqera Labs, the opportunities in sequencing and the challenge of growing into a CEO role.

Read more: Life sciences is ‘going through rapid change’ – opening a software opportunity